NCT05600907View on ClinicalTrials.gov

Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

November 30, 2036

Study Completion Date

November 30, 2036

Conditions
Chronic Granulomatous DiseaseCGD
Interventions
BIOLOGICAL

JSP191

A monoclonal antibody that targets human CD117

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH